New Delhi: Singapore-based healthcare-focused PE firm
Quadria Capital
has announced an
investment
of $102 million (Rs 850 crore) in
NephroPlus
, Asia’s largest dialysis network. Quadria will acquire a significant minority stake through a combination of a primary investment and purchase of₹shares from existing shareholders, a company statement said.
The transaction will support NephroPlus in serving growing demand for high quality, affordable dialysis services across India and other markets in Asia.
Founded in 2010, NephroPlus operates in sizeable, high-growth markets across Asia, with dominant leadership in India and a fast-growing footprint in the Philippines and other Asian countries. Demand for dialysis services in the company’s target markets is expected to grow at a rate of over 11% annually over next five years.
Vikram Vuppala, founder and CEO of NephroPlus, said: “Our business has evolved tremendously over the past few years and today we are proud to be one of the fastest growing and most trusted providers of high-quality dialysis to around 30,000 patients. We look forward to expanding in India, our core market, while exploring further opportunities to bring our expertise and clinical excellence to more patients in other global markets”.
